Li, Na <br/><br/>
Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenström Macroglobulinemia.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  01 2019 
 - 369-377 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-18-1776  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acrylamides--pharmacology<br/>Aminopyridines--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Cytokines--antagonists & inhibitors<br/>DNA Breaks, Double-Stranded--drug effects<br/>DNA Damage--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Nicotinamide Phosphoribosyltransferase--antagonists & inhibitors<br/>Rad51 Recombinase--genetics<br/>Waldenstrom Macroglobulinemia--drug therapy<br/>p21-Activated Kinases--antagonists & inhibitors